UC San Francisco researchers have found a way to double doctors’ accuracy in detecting the vast majority of complex fetal heart defects in utero – when interventions could either correct them or ...
Please provide your email address to receive an email when new articles are posted on . An AI software system improved ultrasound detection of fetal congenital heart defects compared with unaided ...
Scarsdale10583 is the #1 Community Website for Scarsdale, New York offering community news, local events, people, schools, real estate and more.
Heart rate is an important sign of fetal health, yet few technologies exist to easily and inexpensively track fetal heart rates outside of doctors' offices. This can create risks for pregnancies in ...
Medical devicemaker BrightHeart has earned FDA clearance for its artificial intelligence software designed to transform prenatal ultrasound evaluations of the fetal heart. Congenital heart defects ...
PARIS--(BUSINESS WIRE)--BrightHeart, a leading AI innovator in obstetric and pediatric cardiology technology, announces it has received FDA 510(k) clearance for its first artificial intelligence ...
The probe used in a fetal echocardiogram is called a transducer. It emits ultrasonic sound waves into your belly that create an image on the doctor’s screen. These sound waves are at a frequency that ...
ROYAL OAK, Mich. – Researchers at Beaumont Hospital in Royal Oak have discovered a blood test for pregnant people that can detect fetal congenital heart defects before the child is born. The test uses ...
KUWAIT CITY, Feb 17: Dr. Tariq Al-Arabi, a specialist in obstetrics and gynecology, emphasized the importance of combining detailed ultrasound scans with blood tests in the early stages of pregnancy.
BrightHeart, a global leader in AI-driven prenatal ultrasound, today announced the availability of its B-Right AI Platform through GE HealthCare’s Voluson™ Solution Store, bringing advanced AI support ...
Researchers at Beaumont Hospital, Royal Oak, have discovered a blood test for pregnant women that uses artificial intelligence and genetic-related biomarkers to accurately detect, fetal congenital ...
PARIS--(BUSINESS WIRE)--BrightHeart, a leading AI innovator in obstetric and pediatric cardiology technology, announced today that the groundbreaking results of two key studies of the company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results